Presenting cell therapy specificity screening data at PEGS Lisbon
If you are attending the ‘PEGS Essential Protein Engineering Summit’ in Lisbon this week then please do join us for the lunchtime symposium on Wednesday. Our European Business Development Manager, Diogo Rodrigues, will be outlining the Retrogenix cell microarray technology and its role in screening both plasma membrane and secreted proteins for specific interactions. He will present the results from off-target profiling projects, including details of how the data can be used in regulatory submissions.
“Specificity screening of cell therapies against extensive libraries of plasma membrane and secreted protein targets”
Wed 20th November, 1.15pm (CAR T, TIL & TCR Therapy track)
Elizabeth Kingsley and Teodora Pascu will also be attending the event and welcome discussions with delegates on how cell microarray technology is used to identify primary receptors as well as specific off-targets.
If you are not at the event but would like further details about our technology then please do get in touch.